In a relatively large cohort of 190 ALS patients and 130 with other neurological diseases, Rossi et al. confirmed that CSF NFL and p-NFH were valuable diagnostic and prognostic biomarkers in ALS (10). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.